How would you manage a nodal recurrence of cutaneous SCC if the patient is unable to receive surgery for 6-8 weeks?
In a patient who would be otherwise fit for surgery +/- adjuvant RT, and the delay is caused by COVID-related OR staffing issues, what would be your approach?
Would your treatment approach differ depending on adverse features (i.e., ECE, high grade, etc)?
Answer from: Radiation Oncologist at Academic Institution
I’d first consider referring the patient to a center that could perform the operation, as it is standard of care for a patient with resectable cSCC with nodal metastases.
At some centers, there may be a clinical trial of neoadjuvant immunotherapy that could be considered.
If thos...
Sign in or Register to read more